Pharmaceutical Market Consulting Service
Pharmaceutical Market Consulting Service refers to advisory offerings that help manufacturers, biotech and healthcare stakeholders navigate market access, commercialization, regulatory strategy, pricing, and competitive intelligence. These services combine data analytics, industry expertise, and strategic planning to optimize product positioning, accelerate market entry, and maximize lifecycle value in global healthcare markets.

Pharmaceutical Market Consulting Service
In Europe’s pharmaceutical sector, consulting firms are driving growth and innovation through strategic biotech acquisitions, landmark licensing deals, and transformative crosssector partnerships. These firms provide the essential expertise, market intelligence, and strategic guidance that empower pharmaceutical companies to navigate complex deals and unlock new avenues for expansion.

Piero Rijli has over 30 years of experience at the Menarini Group, where he currently serves as Corporate Director, Regulatory Activities and Market Access. He has held global responsibility for international regulatory affairs, pricing, and reimbursement, and serves on the Board of Directors of Menarini Ricerche. By 2015, responsibilities were consolidated with global market access, leading to his current position as corporate director, regulatory activities and market access for the Menarini Group.
